Ziarco Pharma's Acquisition

Ziarco Pharma was acquired by Novartis on December 16, 2016.

Ziarco is a dermatology therapeutics firm that develops a range of oral and topical products for the treatment of atopic dermatitis and psoriasis. Ziarco's lead candidate, ZPL-389, is a once-daily ora…

Articles about Ziarco Pharma's Acquisition: